These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 32279597)

  • 1. Potential medication interactions with paroxetine use for cough in cancer patients.
    Wong AB; Hui L; Hong J
    J Oncol Pharm Pract; 2020 Jul; 26(5):1296. PubMed ID: 32279597
    [No Abstract]   [Full Text] [Related]  

  • 2. Paroxetine for the treatment of intractable and persistent cough in patients diagnosed with cancer.
    Thakerar A; Simadri K; Alexander M; Fullerton S
    J Oncol Pharm Pract; 2020 Jun; 26(4):803-808. PubMed ID: 31446865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author's response to letter: Paroxetine for the treatment of intractable and persistent cough in patients diagnosed with cancer.
    Thakerar A; Simadri K; Alexander M; Fullerton S
    J Oncol Pharm Pract; 2020 Jul; 26(5):1295. PubMed ID: 32295470
    [No Abstract]   [Full Text] [Related]  

  • 4. What has dry cough in common with pruritus? Treatment of dry cough with paroxetine.
    Zylicz Z; Krajnik M
    J Pain Symptom Manage; 2004 Feb; 27(2):180-4. PubMed ID: 15157042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated determination of paroxetine and its main metabolite by column switching and on-line high-performance liquid chromatography.
    Härtter S; Hermes B; Szegedi A; Hiemke C
    Ther Drug Monit; 1994 Aug; 16(4):400-6. PubMed ID: 7974631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin syndrome after lithium add-on medication to paroxetine.
    Sobanski T; Bagli M; Laux G; Rao ML
    Pharmacopsychiatry; 1997 May; 30(3):106-7. PubMed ID: 9211572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CR.
    DeVane CL
    Psychopharmacol Bull; 2003; 37 Suppl 1():29-41. PubMed ID: 14566199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of mirtazapine and paroxetine: possible clinically demonstrated interaction?
    Červeňová J
    Cas Lek Cesk; 2019; 158(7-8):310-313. PubMed ID: 31995999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of prolonged recovery from serotonin syndrome caused by paroxetine].
    Ochiai Y; Katsu H; Okino S; Wakutsu N; Nakayama K
    Seishin Shinkeigaku Zasshi; 2003; 105(12):1532-8. PubMed ID: 15027311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety profile of paroxetine.
    Boyer WF; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I open-label study to investigate the potential drug-drug interaction between single-dose dacomitinib and steady-state paroxetine in healthy volunteers.
    Ruiz-Garcia A; Giri N; LaBadie RR; Ni G; Boutros T; Richie N; Kocinsky HS; Checchio TM; Bello CL
    J Clin Pharmacol; 2014 May; 54(5):555-62. PubMed ID: 24293056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin.
    Andersen BB; Mikkelsen M; Vesterager A; Dam M; Kristensen HB; Pedersen B; Lund J; Mengel H
    Epilepsy Res; 1991; 10(2-3):201-4. PubMed ID: 1840138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations.
    Markowitz JS; Devine CL
    Ther Drug Monit; 1997 Apr; 19(2):244-5. PubMed ID: 9108660
    [No Abstract]   [Full Text] [Related]  

  • 14. Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer.
    Hilleret H; Voirol P; Bovier P; Giannakopoulos P; Zullino D; Baumann P; Giroud C; Rivier L; Eap CB
    Ther Drug Monit; 2002 Aug; 24(4):567-9. PubMed ID: 12142644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.
    Bahar MA; Wang Y; Bos JHJ; Wilffert B; Hak E
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):621-629. PubMed ID: 29575226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects.
    van der Lee MJ; Blenke AA; Rongen GA; Verwey-van Wissen CP; Koopmans PP; Pharo C; Burger DM
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4098-104. PubMed ID: 17846135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of pharmacokinetic interaction of paroxetine and roxithromycin on bencycloquidium bromide in healthy subjects.
    Agbokponto JE; Luo Z; Liu R; Liu Z; Liang M; Ding L
    Eur J Pharm Sci; 2015 Mar; 69():37-43. PubMed ID: 25559065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
    Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of paroxetine in three postmortem cases.
    Vermeulen T
    J Anal Toxicol; 1998 Oct; 22(6):541-4. PubMed ID: 9788532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.